Table 4 Effect of montelukast on peripheral blood eosinophils (K/μL) and total serum IgE (IU/ml)
From: Asthma in the elderly: a double-blind, placebo-controlled study of the effect of montelukast
Baseline | 8 weeks | |
|---|---|---|
Eosinophils (montelukast) | 0.38 ± 0.25 | 0.37 ± 0.32 |
Eosinophils (placebo) | 0.45 ± 0.42 | |
IgE (montelukast) | 182 ± 249 | 184 ± 272 |
IgE (placebo) | 218 ± 358 |